10.1016/S0968-0896(01)00088-8
The research aimed to evaluate the stereoselectivity of chiral analogues of the endogenous cannabinoid receptor ligand, arachidonylethanolamide (anandamide), in binding to CB1 and CB2 cannabinoid receptors and their metabolic stability. The study synthesized several chiral anandamide analogues with methyl groups introduced at the 2,1 and 20 positions using asymmetric synthesis. The researchers found that the introduction of a single 2-methyl group increased affinity for CB1, but only modestly improved metabolic stability. However, the 2,1-dimethyl analogues exhibited high enantio- and diastereoselectivity, with (R)-N-(1-methyl-2-hydroxyethyl)-2-(R)-methyl-arachidonamide (4) showing the highest CB1 receptor affinity. The study concluded that a partial CB1 receptor site model could be proposed, featuring two hydrophobic pockets capable of accommodating 1- and 2-methyl groups. Key chemicals used in the process included arachidonic acid, various amino alcohols, and chiral auxiliaries like 4-benzyl-2-oxazolidinone, along with reagents such as oxalyl chloride, lithium hydroxide, and phenylmethanesulfonyl fluoride (PMSF) for enzyme inhibition during binding assays.
10.1016/j.bmc.2007.08.039
The research focuses on the exploration of structural similarities between anandamide (AEA) and Δ9-tetrahydrocannabinol (Δ9-THC) by designing and synthesizing hybrid structures. The purpose of this study was to broaden the understanding of these structural similarities and to develop novel THC/AEA hybrid ligands with potential novel pharmacological properties. The researchers synthesized a series of hybrid compounds, among which Hybrid 1 (O-2220) demonstrated very high binding affinity to CB1 receptors. The study concluded that the high receptor affinity and pharmacological potency of O-2220 provide further insights into the structural requirements for biological activity shared by THC and AEA, and that the hybrids developed in this study show potential for developing new templates for cannabinoid receptor agonists and antagonists. The chemicals used in the process included various organic compounds such as anandamide, Δ9-THC, and their analogs, as well as reagents like ethanol, emulphor, and saline for drug preparation and administration. Additionally, a range of synthetic intermediates and final hybrid compounds were prepared using a variety of chemical reactions and techniques, as detailed in the chemistry section of the article.